SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-084831
Filing Date
2013-11-14
Accepted
2013-11-14 16:18:28
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19854_110q.htm 10-Q 1024193
2 EX-31.1 a13-19854_1ex31d1.htm EX-31.1 9821
3 EX-31.2 a13-19854_1ex31d2.htm EX-31.2 9800
4 EX-32.1 a13-19854_1ex32d1.htm EX-32.1 6341
5 EX-32.2 a13-19854_1ex32d2.htm EX-32.2 6318
  Complete submission text file 0001104659-13-084831.txt   6848911

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptct-20130930.xml EX-101.INS 789912
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20130930.xsd EX-101.SCH 59331
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20130930_cal.xml EX-101.CAL 49854
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20130930_def.xml EX-101.DEF 343701
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ptct-20130930_lab.xml EX-101.LAB 1029473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20130930_pre.xml EX-101.PRE 535123
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 131220289
SIC: 2834 Pharmaceutical Preparations